Prediction of elimination of intrahepatic cccDNA in hepatitis B virus-infected patients by a combination of noninvasive viral markers
Authors:
- Kosaku KitagawaKKKosaku Kitagawa
- Sanae HayashiSHSanae Hayashi
- Takeshi MatsuiTMTakeshi Matsui
- Masanori AtsukawaMAMasanori Atsukawa
- Natthaya ChuaypenNCNatthaya Chuaypen
- Pisit TangkijvanichPTPisit Tangkijvanich
- Lena AllweissLALena Allweiss
- Takara NishiyamaTNTakara Nishiyama
- Naotoshi NakamuraNNNaotoshi Nakamura
Preprint
Abstract
Evaluation of intrahepatic covalently closed circular DNA (cccDNA) is a key for searching an elimination of hepatitis B virus (HBV) infection. HBV RNA and HBV core-related antigen have been proposed as surrogate markers for evaluating cccDNA activity, although they do not necessarily estimate the amount of cccDNA. Here, we developed a novel multiscale mathematical model describing intra- and inter-cellular viral propagation, based on the experimental quantification data in both HBV-infected cell culture and humanized mouse models. We applied it to HBV-infected patients under treatment and developed a model which can predict intracellular HBV dynamics only by use of noninvasive extracellular surrogate biomarkers. Importantly, the model prediction of the amount of cccDNA in patients over time was confirmed to be well-correlated with the liver biopsy data. Thus, our noninvasive method enables to predict the amount of cccDNA in patients and contributes to determining the treatment endpoint required for elimination of intrahepatic cccDNA.Keywords
This publication has 76 references indexed in Scilit:
- Interleukin-1 and Tumor Necrosis Factor-α Trigger Restriction of Hepatitis B Virus Infection via a Cytidine Deaminase Activation-induced Cytidine Deaminase (AID)Journal of Biological Chemistry, 2013
- Hepatocyte-targeted RNAi Therapeutics for the Treatment of Chronic Hepatitis B Virus InfectionMolecular Therapy, 2013
- IFN-α inhibits HBV transcription and replication in cell culture and in humanized mice by targeting the epigenetic regulation of the nuclear cccDNA minichromosomeJournal of Clinical Investigation, 2012
- Identifying viral parameters from in vitro cell culturesFrontiers in Microbiology, 2012
- Hepatitis B Virus Kinetics under Antiviral Therapy Sheds Light on Differences in Hepatitis B e Antigen Positive and Negative InfectionsThe Journal of Infectious Diseases, 2010
- Tripartite motif‐containing 22 inhibits the activity of hepatitis B virus core promoter, which is dependent on nuclear‐located RING domain†Hepatology, 2009
- Early serum HBsAg drop: A strong predictor of sustained virological response to pegylated interferon alfa-2a in HBeAg-negative patients #Hepatology, 2009
- Hepatitis B Virus Core-Related Antigens as Markers for Monitoring Chronic Hepatitis B InfectionJournal of Clinical Microbiology, 2007
- Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy1 ☆Gastroenterology, 2004
- Modelling viral and immune system dynamicsNature Reviews Immunology, 2002